ArticleJournal of breast cancer2014

Survival benefit of zoledronic Acid in postmenopausal breast cancer patients receiving aromatase inhibitors.

Sung Gwe Ahn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.